P G J Burney1, R L Hooper. 1. National Heart & Lung Institute, Imperial College, London, UK. p.burney@imperial.ac.uk
Abstract
BACKGROUND: In the USA, different standards are usually set for spirometric values in African-American and white populations. It is unclear to what extent the lower lung function found in African-Americans is 'normal' in the sense of having no adverse consequences. METHODS: African-American and white participants in the Atherosclerosis Risk in Communities (ARIC) limited access data set, from four communities in the USA had spirometric testing at baseline beginning in 1986 and were followed up to assess survival to the end of 2002. RESULTS: Forced Expiratory Volume in 1 s (FEV(1)) and Forced Vital Capacity (FVC) were lower in the African-American than the white sample both for men and women and adjustment for potential confounders had little effect on the estimated difference {difference in FVC after adjustment: men, -0.68 l [95% confidence interval (95% CI) -0.75 to -0.61]; women, -0.41 l (95%CI -0.45 to -0.36)}. The FEV(1)/FVC ratio was slightly greater among African-American than white participants [difference: men, 1.5% (95%CI 0.7-2.1); women, 1.7% (95%CI 1.1-2.2)]. After adjustment for age and height, survival was similar in each ethnic group for any given level of FVC before and after adjustment for potential confounders. The hazard ratio for African-American compared with white participants was 1.24 for men (95% CI 0.91-1.69) and 0.96 for women (95% CI 0.66-1.38). CONCLUSIONS: A given FVC has the same prognostic significance for 'normal' African-American and white participants. It is inappropriate to use ethnic norms when assessing prognosis.
BACKGROUND: In the USA, different standards are usually set for spirometric values in African-American and white populations. It is unclear to what extent the lower lung function found in African-Americans is 'normal' in the sense of having no adverse consequences. METHODS: African-American and white participants in the Atherosclerosis Risk in Communities (ARIC) limited access data set, from four communities in the USA had spirometric testing at baseline beginning in 1986 and were followed up to assess survival to the end of 2002. RESULTS: Forced Expiratory Volume in 1 s (FEV(1)) and Forced Vital Capacity (FVC) were lower in the African-American than the white sample both for men and women and adjustment for potential confounders had little effect on the estimated difference {difference in FVC after adjustment: men, -0.68 l [95% confidence interval (95% CI) -0.75 to -0.61]; women, -0.41 l (95%CI -0.45 to -0.36)}. The FEV(1)/FVC ratio was slightly greater among African-American than white participants [difference: men, 1.5% (95%CI 0.7-2.1); women, 1.7% (95%CI 1.1-2.2)]. After adjustment for age and height, survival was similar in each ethnic group for any given level of FVC before and after adjustment for potential confounders. The hazard ratio for African-American compared with white participants was 1.24 for men (95% CI 0.91-1.69) and 0.96 for women (95% CI 0.66-1.38). CONCLUSIONS: A given FVC has the same prognostic significance for 'normal' African-American and white participants. It is inappropriate to use ethnic norms when assessing prognosis.
Authors: Lisa LaVange; Sonia M Davis; John Hankinson; Paul Enright; Rebbecca Wilson; R Graham Barr; Thomas K Aldrich; Ravi Kalhan; Hector Lemus; Ai Ni; Lewis J Smith; Gregory A Talavera Journal: Am J Respir Crit Care Med Date: 2017-10-15 Impact factor: 21.405
Authors: Rune Grønseth; William M Vollmer; Jon A Hardie; Inga Sif Ólafsdóttir; Bernd Lamprecht; A Sonia Buist; Louisa Gnatiuc; Amund Gulsvik; Ane Johannessen; Paul Enright Journal: Eur Respir J Date: 2013-10-31 Impact factor: 16.671
Authors: Daniel O Obaseki; Gregory E Erhabor; Olayemi F Awopeju; Olufemi O Adewole; Bamidele O Adeniyi; Emerita A Sonia Buist; Peter G Burney Journal: Ann Am Thorac Soc Date: 2017-05
Authors: Ana Maria B Menezes; Fernando C Wehrmeister; Fernando P Hartwig; Rogelio Perez-Padilla; Denise P Gigante; Fernando C Barros; Isabel O Oliveira; Gustavo D Ferreira; Bernardo L Horta Journal: Eur Respir J Date: 2015-02-19 Impact factor: 16.671
Authors: Peter Burney; Anamika Jithoo; Bernet Kato; Christer Janson; David Mannino; Ewa Nizankowska-Mogilnicka; Michael Studnicka; Wan Tan; Eric Bateman; Ali Koçabas; William M Vollmer; Thorarrin Gislason; Guy Marks; Parvaiz A Koul; Imed Harrabi; Louisa Gnatiuc; Sonia Buist Journal: Thorax Date: 2013-12-18 Impact factor: 9.139
Authors: Sooky Lum; Vassiliki Bountziouka; Samatha Sonnappa; Angie Wade; Tim J Cole; Seeromanie Harding; Jonathan C K Wells; Chris Griffiths; Philip Treleaven; Rachel Bonner; Jane Kirkby; Simon Lee; Emma Raywood; Sarah Legg; Dave Sears; Philippa Cottam; Colin Feyeraband; Janet Stocks Journal: Eur Respir J Date: 2015-10-22 Impact factor: 16.671
Authors: Sooky Lum; Vassiliki Bountziouka; Philip Quanjer; Samatha Sonnappa; Angela Wade; Caroline Beardsmore; Sunil K Chhabra; Rajesh K Chudasama; Derek G Cook; Seeromanie Harding; Claudia E Kuehni; K V V Prasad; Peter H Whincup; Simon Lee; Janet Stocks Journal: PLoS One Date: 2016-04-27 Impact factor: 3.240